Drug General Information
Drug ID	D0NY7A
Former ID	DNC001255
Drug Name	S-19528
Indication	Eating disorders reduction in food intake [ICD9: 307.5; ICD10:F50]		Investigative	[536225]
Company	Servier
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Neuropeptide Y receptor type 1	Target Info	Antagonist	[536225]
	Neuropeptide Y receptor 5	Target Info	Antagonist	[536225]
KEGG Pathway	cAMP signaling pathway
	Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
NetPath Pathway	FSH Signaling Pathway
Reactome	Peptide ligand-binding receptors
	G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	Endothelin Pathways
	GPCR ligand binding
	GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
	GPCR downstream signaling
References
Ref 536225	Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.
Ref 536225	Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.